抄録
Purpose Percutaneous radiofrequency ablation for renal tumor could be a useful modality as minimally invasive and palliative therapy. In this study we evaluated their feasibility and safety.
Methods Between 2004 and 2011, real-time CT guided radiofrequency ablation was perfomed to ablate a total of 16 tumors in 13 patients. We recorded whether tumors were successfully ablated, major complications and changes of creatinine clearance before and after RFA.
Results Overall 11 of 13 (84.6%) were successfully ablated with radiofrequency ablation but 2 had local recurrent tumors. There was no significant change in creatinine clearance between before and after RFA. Two minor complications as pararenal hemorrhage were observed.
Conclusion Percutaneous radiofrequency is a feasible and safe modality as a minimally invasive therapy.
